NAC Logo

Health Professionals
Asthma Management HandbookAsthma Action PlansSpirometry ResourcesInformation PapersOther ResourcesProfessional Development
Asthma Management Handbook 2006
Home
AMH 2006 PDF - for print
Member Organisations
Sponsors
Contributors
Note to the Sixth Edition
Contents
Introduction
Levels of evidence
Asthma: the basic facts
Diagnosis in adults
Diagnosis in children
Principles of drug therapy
Drugs and devices
Acute asthma
Managing exacerbations
Complementary medicine
Diet and asthma
Asthma and allergy
Ongoing care
Smoking and asthma
COPD and asthma
Exercise-induced asthma
Occupational asthma
Pregnancy and asthma
Asthma in the elderly
Other comorbidities
Prevention
Appendices
References
Errata

Home arrow Asthma and allergy
Print E-mail

Asthma and allergy

SUMMARY OF PRACTICE POINTS

LEVEL OF EVIDENCE
Inhalant allergens are a major trigger for asthma and wheezing in allergic individuals. In sensitised individuals, exposure to house dust mite, pollen, domestic pets, moulds or cockroaches can trigger asthma attacks or worsen symptoms. II
There is no definitive evidence that strategies to reduce exposure to house dust mites are effective in controlling asthma. However, some patients may benefit from these strategies. [√]
Food allergens are uncommon triggers for asthma. II
Acute food allergen-induced respiratory symptoms may be due to anaphylaxis, not asthma – particularly if associated with urticaria or angioedema. [√]
Ensure responsible food allergens are accurately identified and appropriate avoidance strategies are instituted. This will usually entail referral to a specialist with experience in allergy and clinical immunology. [√]
Intranasal corticosteroids are the most effective medications for controlling symptoms of allergic rhinitis. I
Specific allergen immunotherapy might reduce the risk of childhood rhinitis progressing to asthma. II
Specific immunotherapy (SIT) has clear therapeutic benefits in asthma. I
Pre-treatment with less-sedating H1-antihistamines can significantly reduce local and systemic adverse reactions to immunotherapy. II
Immunotherapy is contraindicated in patients with severe or unstable asthma. IV

There is a strong association between allergy (sensitisation to allergens) and asthma, although these processes appear to develop independently.1

  • Asthma is regarded as one of the final stages of the ‘atopic march', which frequently begins in infancy as food allergy and atopic dermatitis. As many as 80% of infants with early evidence of allergic disease will go on to develop asthma or allergic rhinitis.2
  • Early allergic sensitisation is a major risk factor for persistent wheezing and airway hyperreactivity.3,4
  • Allergic individuals are over three times more likely to develop asthma5 and airway hyperresponsiveness.6 Around 70-90% of individuals with established asthma show hypersensitivity to one or more allergens,6,7 and this proportion is higher among children than adults.

 

Content Created (Thursday, 16 November 2006)

Last Updated ( Thursday, 31 May 2007 )
 
Next >
Advanced Search AMH 2006
Search NAC Website
AMH 2006 PDF - for print
Obtain the AMH 2006
Login





Lost Password?
No account yet? Register
Top 20 AMH 2006 areas